MARKET

HTBX

HTBX

Heat Biologics
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.5700
-0.0389
-6.39%
Closed 16:00 09/20 EDT
OPEN
0.5920
PREV CLOSE
0.6089
HIGH
0.6198
LOW
0.5400
VOLUME
151.50K
TURNOVER
--
52 WEEK HIGH
2.240
52 WEEK LOW
0.4600
MARKET CAP
19.42M
P/E (TTM)
-0.8671
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of HTBX and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

HTBX News

  • Stocks That Hit 52-Week Lows On Wednesday
  • Benzinga.09/04 15:39
  • 32 Healthcare Stocks Moving In Tuesday's Pre-Market Session
  • Benzinga.09/03 12:42
  • Introducing Heat Biologics (NASDAQ:HTBX), The Stock That Collapsed 99%
  • Simply Wall St..08/27 13:44
  • HTBX: HS-130 Ready To Go
  • Zacks Small Cap Research.08/26 16:30

More

Industry

Biotechnology & Medical Research
+0.62%
Pharmaceuticals & Medical Research
+0.95%

Hot Stocks

Name
Price
%Change

About HTBX

Heat Biologics, Inc. is a development-stage company focused on developing allogeneic, off-the-shelf cellular therapeutic vaccines to combat a range of cancers. The Company is an immuno-oncology company, which focuses on T cell-stimulating platform technologies, such as Immune Pan-Antigen Cytotoxic Therapy (ImPACT) and Combination Pan-Antigen Cytotoxic Therapy (ComPACT). Using its ImPACT platform technology, the Company has developed HS-410 (vesigenurtacel-L) as a product candidate to treat non-muscle invasive bladder cancer (NMIBC), and HS-110 (viagenpumatucel-L), which is intended for use in combination with an anti-PD-1 checkpoint inhibitor, as a potential treatment for patients with non-small cell lung cancer (NSCLC). Using its ComPACT platform technology, it has developed HS-120 as a potential treatment for NSCLC. It is conducting a Phase II trial of HS-410 in patients with NMIBC, and a Phase Ib trial of HS-110, in combination with nivolumab (Opdivo) to treat patients with NSCLC.
More

Webull offers Heat Biologics Inc (HTBX) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.